Insulin Glargine Controversy: A Tribute to the Editorial Team at Diabetologia

par Butler, Peter C.
Publié 2009

Farewell Statement From Dr. Peter Butler as Outgoing Editor in Chief of Diabetes

par Butler, Peter C.
Publié 2011

Glucagon-Like Peptide 1 Drugs as Second-Line Therapy for Type 2 Diabetes

par Butler, Peter C.
Publié dans JAMA Intern Med (2016)

Insulin Degrading Enzyme inhibition, a novel therapy for type 2 diabetes?

par Costes, Safia, Butler, Peter C.
Publié 2014

GLP-1–Based Therapy for Diabetes: What You Do Not Know Can Hurt You

par Butler, Peter C., Dry, Sarah, Elashoff, Robert
Publié 2010

Evaluation of immunohistochemical staining for glucagon in human pancreatic tissue

par Gurlo, Tatyana, Butler, Peter C., Butler, Alexandra E.
Publié dans J Histotechnol (2016)

Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein

par Matveyenko, Aleksey V., Veldhuis, Johannes D., Butler, Peter C.
Publié 2008

Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and β-cell mass to age-related insulin resistance in rats

par Matveyenko, Aleksey V., Veldhuis, Johannes D., Butler, Peter C.
Publié 2008

Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes

par Satin, Leslie S., Butler, Peter C., Ha, Joon, Sherman, Arthur S.
Publié dans Mol Aspects Med (2015)

Many Commercially Available Antibodies for Detection of CHOP Expression as a Marker of Endoplasmic Reticulum Stress Fail Specificity Evaluation

par Haataja, Leena, Gurlo, Tatyana, Huang, Chang-jiang, Butler, Peter C.
Publié 2008

Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis

par Haataja, Leena, Gurlo, Tatyana, Huang, Chang J., Butler, Peter C.
Publié 2008

Response to Comment on: Saisho et al. β-Cell Mass and Turnover in Humans: Effects of Obesity and Aging. Diabetes Care 2013;36:111–117

par Saisho, Yoshifumi, Butler, Alexandra E., Manesso, Erica, Butler, Peter C.
Publié 2013

Inconsistent formation and nonfunction of insulin-positive cells from pancreatic endoderm derived from human embryonic stem cells in athymic nude rats

par Matveyenko, Aleksey V., Georgia, Senta, Bhushan, Anil, Butler, Peter C.
Publié 2010

UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β-cells: Evidence of interplay between the ubiquitin/proteasome system and autophagy

par Costes, Safia, Gurlo, Tatyana, Rivera, Jacqueline F, Butler, Peter C
Publié 2014

Type 2 Diabetes as a Protein Misfolding Disease

par Mukherjee, Abhisek, Morales-Scheihing, Diego, Butler, Peter C., Soto, Claudio
Publié dans Trends Mol Med (2015)

Increased Proliferation of the Pancreatic Duct Gland Compartment in Type 1 Diabetes

par Moin, Abu Saleh Md, Butler, Peter C., Butler, Alexandra E.
Publié dans J Clin Endocrinol Metab (2016)

A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?

par Butler, Peter C., Elashoff, Michael, Elashoff, Robert, Gale, Edwin A.M.
Publié 2013

Down Syndrome-Associated Diabetes Is Not Due To a Congenital Deficiency in β Cells

par Butler, Alexandra E., Sacks, Wendy, Rizza, Robert A., Butler, Peter C.
Publié dans J Endocr Soc (2017)

Cyclin-Dependent Kinase 5 Promotes Pancreatic β-Cell Survival via Fak-Akt Signaling Pathways

par Daval, Marie, Gurlo, Tatyana, Costes, Safia, Huang, Chang-jiang, Butler, Peter C.
Publié 2011

β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?

par Costes, Safia, Langen, Ralf, Gurlo, Tatyana, Matveyenko, Aleksey V., Butler, Peter C.
Publié 2013